Document:

First Amendment Technology License Agreement

 EXHIBIT 10.36 
 FIRST AMENDMENT TO TECHNOLOGY LICENSE AGREEMENT 
 BETWEEN 
 SALUMEDICA, LLC 
 AND

 SPINEMEDICA CORP. 
 THIS FIRST AMENDMENT TO TECHNOLOGY LICENSE AGREEMENT (this “Amendment”) is entered into as of the 3rd day of August, 2007 (the “Effective Date”), by and between
SaluMedica, LLC, a Georgia limited liability company (“Licensor”), and SpineMedica Corp., a Florida corporation (“SpineMedica”; and, together with any subsidiary, sublicensee, successor, or assignee of
SpineMedica, “Licensee”), under the following circumstances: 
 WHEREAS, Licensor and Licensee entered
into that certain Technology License Agreement, dated August 3, 2007 (the “License Agreement”), concerning Licensed Technology (as defined therein) for all neurological and orthopedic uses, including muscular and
skeletal uses, related to the rotator cuff and the hand (excluding the wrist); and 
 WHEREAS, Licensor and Licensee desire
to make certain amendments to the License Agreement; 
 NOW, THEREFORE, in consideration of ten U.S. dollars ($10.00) in hand
paid and the promises, representations, and mutual covenants contained herein, the parties hereto, intending to be legally bound, mutually agree as follows: 
 1. Definition of SaluBridge. The License Agreement is hereby amended by adding the following definition: 
 “‘SaluBridge’ means that certain product or device known as
‘SaluBridge Nerve Cuff’ or ‘SaluMedica Nerve Cuff’ made out of SalubriaTM Biomaterial for which a Section 510(k) notification (no. K002098) was filed with the U.S.
Food and Drug Administration on September 25, 2000.” 
 2. Exclusion of SaluBridge. The
License Agreement is hereby amended by deleting Section 1.13 thereof (the definition of “Licensed Product”) and Section 1.14 thereof (the definition of “Licensed Technology”) in their entirety and inserting in lieu
thereof the following: 
 “‘Licensed Product’ means any product or device (other than the SaluBridge to the
extent it may be used to provide a protective environment for peripheral nerve repair after injury) that is developed, manufactured, produced, expressed, used, or licensed for use by Licensee, its affiliates, successors, or sublicensees, or their
contract manufacturers, utilizing the Licensed Technology in the Field of Use.” 

 “‘Licensed
Technology’ means the Licensed Patents, Confidential Information, Know How, and Improvements solely as they relate to the Field of Use, in each and every case. ‘Licensed Technology’ shall not include the SaluBridge to the extent it
may be used to provide a protective environment for peripheral nerve repair after injury, but shall include the SalubriaTM Biomaterial with respect to any other uses.” 
 3. Manufacturing Rights. The License Agreement is hereby amended by deleting Section 1.21 thereof (the
definition of “Practice”) in its entirety and inserting in lieu thereof the following: 
 “‘Practice’
means to make, have made, manufacture, have manufactured, use, offer to sell, sell, market, distribute, or import Licensed Products.” 
 4. Deletion of Definition of Improvement Cooperation Period. The License Agreement is hereby amended by: (a) deleting Section 1.7 thereof (the definition of “Improvement Cooperation
Period”) in its entirety; (b) deleting the sentence “Either Party must give notice to the other of any transaction by such Party resulting in the termination of the Improvement Cooperation Period.” from Section 8.2 of the
License Agreement; and (c) deleting all references to “Improvement Cooperation Period” in the License Agreement and inserting in lieu thereof “term of this License Agreement.” 
 5. Effectiveness. Except as hereby amended, the License Agreement shall continue in full force and effect in
accordance with its original terms. 
 [signatures follow on the next page] 
  

 2 

 IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Technology
License Agreement to be duly executed and delivered as of the Effective Date. 
  
  

									
	 LICENSOR
	 		 	 LICENSEE

			
	 SALUMEDICA, LLC
	 		 	 SPINEMEDICA, LLC, as successor to
 SPINEMEDICA CORP.

					
	 By:
	 	 /s/ Robert R. Singer
	 		 	 By:
	 	  

	 Name:
	 	 Robert R. Singer
	 		 	 Name:
	 	  

	 Title:
	 	 President
	 		 	 Title:
	 	  

				
	 By:
	 	 /s/ Robert B. Braden
	 		 	 OR

	 Name:
	 	 Robert B. Braden
	 		 		 	
	 Title:
	 	 Manager
	 		 	 MIMEDX, INC.

					
		 		 		 	 By:
	 	 /s/ Thomas D’Alonzo

		 		 		 	 Name:
	 	 Thomas D’Alonzo

		 		 		 	 Title:
	 	 CEO

  

 3Trademark License Agreement

 EXHIBIT 10.37 
 TRADEMARK LICENSE AGREEMENT 
 This Trademark License Agreement
(“Agreement”), entered into and effective as of the latest date indicated in the signature block at the foot of this Agreement (the “Effective Date”), is by and between SALUMEDICA, LLC, a Georgia Limited Liability Company with
offices located at 112 Krog Street, Suite 4, Atlanta, Georgia 30307 (“SaluMedica” or the “Licensor”); and SpineMedica Corp., a Florida Corporation with offices located at 1234 Airport Road, Suite 105 Destin, Florida 32541
(“SpineMedica” or the “Licensee”). 
 BACKGROUND 
 WHEREAS SaluMedica is the owner of certain intellectual property rights; and 
 WHEREAS SpineMedica is desirous obtaining and commercializing these intellectual property rights under the terms set forth below.

 NOW THEREFORE, in consideration of ten dollars ($10) in hand paid, the execution and delivery on the date hereof that
certain Technology License Agreement between the parties (the “Technology License”), and the promised performance by each of the parties of the terms set forth herein, the parties hereto, intending to be legally bound, mutually agree as
follows: 
 TERMS OF AGREEMENT 
 I. Grant of License 
 1.1 SaluMedica hereby grants SpineMedica an exclusive, royalty free, fully paid,
worldwide, perpetual (except as provided herein license (“License”) to use the trademark(s) and associated trademark registration(s) listed in Exhibit “A” (the “Trademark Portfolio”) in connection with neurological and
orthopedic uses, including muscular and skeletal uses, related to the rotator cuff and the hand (excluding the wrist) (the “Licensed Field of Use”). 
 1.2 SaluMedica may terminate this Agreement if SpineMedica is in material breach of this Agreement and has not cured the breach within sixty (60) days written notice of such breach, and the
Agreement will alternatively terminate upon the occurrence of the first of the following events: 
 (a) SpineMedica may
terminate this Agreement with thirty (30) days written notice; 
 (b) SaluMedica may terminate this Agreement with
thirty (30) days written notice if it terminates the Technology License. 
 (c) this Agreement will automatically
terminate if SpineMedica files for bankruptcy protection, and in this event SaluMedica may, at its own discretion, elect to assume or cancel any sublicenses that SpineMedica has granted under this Agreement; 
 (d) this Agreement will automatically terminate, on an asset-by-asset basis, if SpineMedica abandons use of any asset in the Trademark
Portfolio. In the event that 

  

 Page 1 of 8 

 
SpineMedica elects to affirmatively abandon use of any asset in the Trademark Portfolio, it will promptly provide SaluMedica with written notice of this
decision. 
 1.3 SpineMedica may sublicense its rights under this Agreement provided that the sublicense includes a written
agreement that imposes substantially the same obligations on the sublicensee, and grants both SaluMedica and SpineMedica the same rights of trademark protection, as those stated in Article III of this Agreement. SpineMedica will promptly provide
SaluMedica with written notice of any such sublicense. 
 1.4 SaluMedica may not use, assign or otherwise transfer any rights
to the Trademark Portfolio within the Licensed Field of Use. 
 1.5 SaluMedica may assume or collateralize this Agreement, in
whole or in part, and will promptly provide SpineMedica with written notice of any such agreement. 
 1.6 SpineMedica may
assume or collateralize this Agreement, in whole or in part, and will promptly provide SaluMedica with written notice of any such agreement. 
 1.7 In the event that SaluMedica elects to abandon any assets in the Trademark Portfolio, then SpineMedica may elect to receive an assignment of that asset, subject to any sublicenses that SaluMedica has granted to
third parties in that asset, at no cost to SpineMedica. 
 1.8 In the event that SaluMedica files for bankruptcy protection,
then SpineMedica may elect to receive an assignment of the Trademark Portfolio, subject to any sublicenses that SaluMedica has granted to third parties in the Trademark Portfolio, at no cost to SpineMedica. 
 II. Payment 
 2.1 The License granted to SpineMedica in this Agreement is fully paid and may not be rescinded. 
 III. Protection Of
Trademark Rights 
 3.1 SaluMedica will have the right and responsibility to maintain and renew the trademark
registrations(s) in the Trademark Portfolio at its sole cost and discretion. 
 3.2 SpineMedica will promptly notify
SaluMedica if it becomes aware of any entity that is apparently infringing an asset in the Trademark Portfolio. 
 3.3
SaluMedica will promptly notify SpineMedica if it becomes aware of any entity that is apparently infringing an asset in the Trademark Portfolio. 
 3.4 Neither party will be required by this Agreement to become a party to any adversarial proceeding including, by way of example, any dispute, litigation, arbitration, mediation, administrative proceeding, or
regulatory proceeding. 
  

 Page 2 of 8 

 3.5 SaluMedica will have the first right to elect to enforce or defend the assets in the
Trademark Portfolio outside the Licensed Field of Use at its sole cost and retain any and all proceeds and other benefits resulting from such enforcement. 
 3.6 Each party will provide reasonable cooperation in connection with any adversarial proceeding conducted by the other party involving any asset in the Trademark Portfolio including, by way of example, producing
documents, answering interrogatories and sitting for depositions, at no cost to the other party other than recovery of its actual out-of-pocket expenses directly incurred in providing such cooperation. 
 3.7 In the event that SaluMedica determines that it will not enforce or defend any right in the Trademark Portfolio outside the Licensed
Field of Use after receiving sixty (60) days written notice of an apparent infringement, then, subject to any sublicenses that SaluMedica has granted to third parties, SpineMedica may elect to enforce such right in its own name and at its sole
cost for past, presently occurring, and future infringements and retain any and all proceeds and other benefits resulting from such enforcement. In the event that SpineMedica elects to enforce trademark rights under this paragraph, then SaluMedica
will assign the subject trademark(s) and trademark registration(s) to SpineMedica subject to an exclusive license (subject to any sublicenses to third parties that SaluMedica may have granted) back to SaluMedica for use of the Trademark Portfolio
outside the Licensed Field of Use. 
 3.8 SpineMedica will have the first right to elect to enforce or defend the assets in
the Trademark Portfolio within the Licensed Field of Use at its sole cost and retain any and all proceeds and other benefits resulting from such enforcement. 
 3.9 In the event that SpineMedica determines that it will not enforce or defend any right in the Trademark Portfolio within the Licensed Field of Use after receiving sixty (60) days written
notice of an apparent infringement within the Licensed Field of Use, then SaluMedica may elect to enforce such right in its own name and at its sole cost for past, presently occurring, and future infringements and retain any and all proceeds and
other benefits resulting from such enforcement. 
 3.10 SpineMedica will only use the assets in the Trademark Portfolio in
the Licensed Field of Use and in accordance with applicable federal, state and local laws, and administrative regulations. 
 3.11 SpineMedica will only use the assets in the Trademark Portfolio in accordance with reasonable standards of quality and propriety to be established by SaluMedica from time-to-time. SaluMedica will provide SpineMedica with written notice
of its standards of quality and propriety. 
 3.12 Upon reasonable notice and conditions, SaluMedica will have the right to
inspect all records in the possession of SpineMedica pertaining to the quality of any goods or services provided by SpineMedica under the Trademark Portfolio including, without limitation, records pertaining to any complaints, civil litigation,
regulatory or law enforcement activity. 
 3.13 In the event that SaluMedica determines in good faith that the goods or
services provided by SpineMedica under the Trademark Portfolio, or the use of the Trademark Portfolio 

  

 Page 3 of 8 

 
by SpineMedica in advertising or other publicly available materials, is objectionable to SaluMedica for any reason whatsoever, SaluMedica will provide
SpineMedica with timely notice of the objectionable circumstances. If SaluMedica believes that the objectionable circumstances can be cured, SaluMedica will advise SpineMedica of the steps that it may elect to undertake to cure the objectionable
circumstances. Failure of SpineMedica to implement such steps to SaluMedica’s reasonable satisfaction will constitute a material breach and basis for termination of this Agreement. Repetitive failure by SpineMedica to adhere to the standards of
quality and propriety established by SaluMedica will constitute a material breach and basis for termination of this Agreement. 
 3.14 Any party found by a court of competent jurisdiction (or the selected authority should the parties elect alternative dispute resolution) to be in breach of this Agreement will pay the other party’s reasonable costs and
attorneys’ fee incurred in connection with enforcing this Agreement. 
 IV. Warranties And Indemnities 
 4.1 SaluMedica represents and warrants that it reasonably believes itself to be the sole owner of all of the assets in the Trademark
Portfolio. 
 4.2 SaluMedica represents and warrants that it has not conveyed any right or interest in the Trademark
Portfolio to any other party. 
 4.3 SaluMedica represents and warrants that it has obtained all corporate, member and/or
shareholder authorization(s) and has an unencumbered legal right to enter into and perform as required by this Agreement. 
 4.4 SpineMedica represents and warrants that it has obtained all corporate, member and/or shareholder authorization(s) and has an unencumbered legal right to enter into and perform as required by this Agreement. 
 4.5 SALUMEDICA MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND AS TO THE VALIDITY OF ANY ASSET IN TRADEMARK PORTFOLIO, WHETHER ANY ASSETS
DESCRIBED IN THE TRADEMARK PORTFOLIO DO OR DO NOT INFRINGE ANY TRADEMARK, COPYRIGHT OR OTHER RIGHT OF ANY THIRD PARTY WHETHER ANY ASSETS IN THE TRADEMARK PORTFOLIO ARE MERCHANTABLE FOR ANY PURPOSE. 
 4.6 SpineMedica shall indemnify, hold harmless, and defend SaluMedica with respect to any claim or cause of action arising out of
publication, advertising or use of any asset in the Trademark Portfolio; or manufacture, use, sale or importation of any product or process under any asset in the Trademark Portfolio, by SpineMedica or its sublicensees including, without limitation,
advertising injury, product liability, medical malpractice, or loss or damage to medical or other data. 
 4.7 SpineMedica
shall indemnify, hold harmless, and defend SaluMedica with respect to any right, claim or cause of action arising out of sublicensing or assignment by SpineMedica of any right in the Trademark Portfolio. 
  

 Page 4 of 8 

 4.8 SaluMedica shall indemnify, hold harmless, and defend SpineMedica with respect to any
claim or cause of action arising out of publication, advertising or use of any asset in the Trademark Portfolio; or manufacture, use, sale or importation of any product or process under any asset in the Trademark Portfolio, by SaluMedica or its
sublicensees (other than SpineMedica and its sublicensees) including, without limitation, advertising injury, personal injury, product liability, medical malpractice, or loss or damage to medical or other data. 
 4.9 SaluMedica shall indemnify, hold harmless, and defend SpineMedica with respect to any right, claim or cause of action arising out of
sublicensing or assignment by SaluMedica of any right in the Trademark Portfolio to any party other than SpineMedica. 
 V.
Miscellaneous 
 5.1 All notices, requests, payments, instructions or other documents to be given hereunder shall be
in writing or by written telecommunication, and shall be deemed to have been duly given if (i) delivered personally (effective upon delivery), (ii) mailed by certified mail, return receipt requested, postage prepaid (effective upon
receipt), (iii) sent by a reputable, established international courier service that guarantees delivery within the next three following business days (effective upon receipt), or (iv) sent by telecopier followed within twenty-four
(24) hours by confirmation by one of the foregoing methods (effective upon receipt of the telephone in complete, readable form), addressed as follows (or to such other address as the recipient may have furnished for the purpose pursuant to this
Section 8.1): 
 If to Licensor: 
 SaluMedica, LLC 
 112 Krog Street, Suite 4 
 Atlanta, Georgia 30307

 Attention: President 
 Facsimile: (404) 589-1838 
 And to: 
 Randall W. Johnson, Esq. 
 5967 Hugh Howell Road 
 Stone Mountain, GA 30087 
 If to Licensee: 

SpineMedica Corp. 
 112 Krog Street, Suite 5 
 Atlanta, Georgia 30307

 Attention: Lew Bennett, President and CEO 
 Facsimile: (678) 916-4745 
 Changes to the above notification addresses may be made by notice to the Parties in the manner set forth above, 
  

 Page 5 of 8 

 5.2 This Agreement constitutes the entire agreement between the parties with respect to
the subject matter hereof, supersedes all previous express or implied promises or understandings related to the subject matter of hereof, and may not be varied, amended, or supplemented except by a writing of even or subsequent date executed by both
parties and containing express reference to this Agreement. The parties acknowledge the existence of a contemporaneously executed Technology License Agreement that is not altered or superseded by the present Agreement, and that this Agreement is not
altered or superseded by the Technology License Agreement. 
 5.3 The failure of either party to force at any time any of the
provisions of this Agreement, or any rights in respect thereto, will in no way be considered a waiver of such provisions, rights, or elections with respect to subsequent events or in any way to affect the validity and the enforceability of this
Agreement. 
 5.4 In the event that any provision of this Agreement is declared invalid or legally unenforceable by a court
of competent jurisdiction from which no appeal is or can be taken, the invalid provision will be deemed replaced by a similar but valid and legally enforceable provision as near in effect as the invalid or legally unenforceable provision, and
remainder of this Agreement will be deemed modified to conform thereto and will remain in effect. 
 5.5 This Agreement will
be binding upon and inure to the benefit of the parties and their respective heirs, successors and permitted assigns. 
 5.6
Each Parties acknowledges that it has been represented by counsel in connection with the negotiation and drafting of this Agreement and that no rule of strict construction shall be applied to either of them as the drafter of all or any part of this
Agreement. 
  

 Page 6 of 8 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement in duplicate, each of
which constitutes an original, to be effective as of the latest year and date indicated below. 
  

									
	 Agreed to:
	 		 	 Agreed to:

	 SALUMEDICA, LLC
	 		 	 SPINEMEDICA, LLC, as successor to

		 		 	 SPINEMEDICA CORP.

					
	 By:
	 	 /s/ Robert R. Singer
	 		 	 By:
	 	 /s/ Rebeccah Brown

	 Name:
	 	 Robert R. Singer
	 		 	 Name:
	 	 Rebeccah Brown

	 Title:
	 	 President
	 		 	 Title:
	 	 VP, Operations

	 Date:
	 	 8/13/2007
	 		 	 Date:
	 	 8/3/2007

				
	 By:
	 	 /s/ Robert B. Braden
	 		 	 Licensee:

	 Name:
	 	 Robert B. Braden
	 		 		 	
	 Title:
	 	 Manager
	 		 	 SPINEMEDICA, LLC, as successor to

	 Date:
	 	 8/13/2007
	 		 	 SPINEMEDICA CORP.

					
		 		 		 	 By:
	 	  

		 		 		 	 Name:
	 	  

		 		 		 	 Title:
	 	  

		 		 		 	 Date:
	 	  

					
		 		 		 	 Or
	 	
				
		 		 		 	 MIMEDX, INC.

					
		 		 		 	 By:
	 	 /s/ Thomas W. D’Alonzo

		 		 		 	 Name:
	 	 Thomas W. D’Alonzo

		 		 		 	 Title:
	 	 CEO

		 		 		 	 Date:
	 	 8/3/2007

  

 Page 7 of 8 

 TRADEMARK LICENSE AGREEMENT 
 BY AND BETWEEN SALUMEDICA, LLC AND SPINEMEDICA CORP. 
 TRADEMARK PORTFOLIO

 EXHIBIT “A” 
 United States Trademark Registrations 
  

	1.	 SALUBRIA, and U.S. Trademark Registration No. 2,588,889 

  

	2.	 SaluMedica 

  

 Page 8 of 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]